Lemonaid Health
870 Market Street, Suite 415, San Francisco, CA, 94102, USA
Overview
Lemonaid Health is an on-demand platform connecting patients with U.S.-licensed doctors and nurse practitioners for consultation through treatment nationwide. The company provides care for conditions including anxiety and depression, UTIs, birth control, hair loss, hypothyroidism, erectile dysfunction, genital herpes and sinus infections, and offers free, fast delivery of prescription medications. Its proprietary technology platform integrates clinical algorithms and decision-support tools with clinician care, and it follows evidence-based guidelines and updated clinical protocols to deliver quality care at lower cost. Led by co-founder and CEO Paul Johnson, Lemonaid operates as an independent healthcare provider. The company plans to use new funding to expand its team of medical professionals and broaden services to include treatment for asthma, hypertension, Type 2 diabetes and additional mental-health services. Financially, the company has raised a total of $55M to date, including the recent Series B. Lemonaid Health operates a custom-built telehealth platform that leverages evidence-based guidelines and up-to-date clinical protocols to provide care for conditions such as acid reflux, erectile dysfunction, flu, hair loss, UTIs and birth control. Board-certified doctors evaluate patients and, when appropriate, recommend treatments and send prescriptions to the pharmacy of choice. The service is accessible from any modern web browser and via iOS and Android apps, and is available in 14 states. Led by Paul Johnson, the company intends to use new funds to continue innovating in online healthcare and to expand its operating footprint. The company recently completed an $11m Series A financing to support those plans. Icebreaker Health operates a telemedicine platform with a strong emphasis on security and HIPAA compliance. Its platform includes data encrypted at the file level, 24/7 monitoring and patching, HITECH-certified servers for HIPAA, penetration testing, and an intrusion detection system. The company also offers automated log monitoring and documented HIPAA risk assessments specific to every project, and maintains technology E&O and data privacy insurance. The business is led by Paul Johnson and Ian Van Every. In August 2015 the company raised $6.6M in funding, with an initial SEC filing target of $6.87M. That offering was supported by 24 unknown/undisclosed investors.
- Total raised
- $51M
- Funding rounds
- 3
- Latest round
- Series B
- Latest activity
- Jul 2020
Industries
- Artificial Intelligence (AI)
- Health Care
- Machine Learning
- Medical
- Telehealth
Recent funding
Series B
Jul 2020
$33M
Series A
May 2017
$11M
Equity
Aug 2015
$7M